Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

The impact of demographic and clinical characteristics on diabetic painful neuropathy.

Assunção A, Campos D, Marques R, Cunha I, Santos P, Martins A, Gonçalves AS, Rebelo A, Lima C, Matos C, Prata AC, Teixeira JT, Duarte L, Belo M, Figueiredo P, Rosa TL.

Rom J Intern Med. 2019 Aug 24. pii: /j/rjim.ahead-of-print/rjim-2019-0019/rjim-2019-0019.xml. doi: 10.2478/rjim-2019-0019. [Epub ahead of print]

PMID:
31446430
2.

Is health related quality of life influenced by diabetic neuropathic pain among type II diabetes mellitus patients in Ethiopia?

Degu H, Wondimagegnehu A, Yifru YM, Belachew A.

PLoS One. 2019 Feb 4;14(2):e0211449. doi: 10.1371/journal.pone.0211449. eCollection 2019.

3.

Prevalence and biochemical risk factors of diabetic peripheral neuropathy with or without neuropathic pain in Taiwanese adults with type 2 diabetes mellitus.

Pai YW, Lin CH, Lee IT, Chang MH.

Diabetes Metab Syndr. 2018 Apr - Jun;12(2):111-116. doi: 10.1016/j.dsx.2017.09.013. Epub 2017 Sep 28.

PMID:
29042249
4.

Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes.

Gibbons CH, Freeman R.

Brain. 2015 Jan;138(Pt 1):43-52. doi: 10.1093/brain/awu307. Epub 2014 Nov 11.

5.

Painful diabetic neuropathy: clinical aspects.

Didangelos T, Doupis J, Veves A.

Handb Clin Neurol. 2014;126:53-61. doi: 10.1016/B978-0-444-53480-4.00005-9. Review.

PMID:
25410214
6.

Prevalence of painful diabetic peripheral neuropathy among patients suffering from diabetes mellitus in Saudi Arabia.

Halawa MR, Karawagh A, Zeidan A, Mahmoud AE, Sakr M, Hegazy A.

Curr Med Res Opin. 2010 Feb;26(2):337-43. doi: 10.1185/03007990903471940.

PMID:
19968592
7.

Plantar pressure as a risk assessment tool for diabetic foot ulceration in egyptian patients with diabetes.

Fawzy OA, Arafa AI, El Wakeel MA, Abdul Kareem SH.

Clin Med Insights Endocrinol Diabetes. 2014 Dec 2;7:31-9. doi: 10.4137/CMED.S17088. eCollection 2014.

8.

Sensory phenotype and risk factors for painful diabetic neuropathy: a cross-sectional observational study.

Raputova J, Srotova I, Vlckova E, Sommer C, Üçeyler N, Birklein F, Rittner HL, Rebhorn C, Adamova B, Kovalova I, Kralickova Nekvapilova E, Forer L, Belobradkova J, Olsovsky J, Weber P, Dusek L, Jarkovsky J, Bednarik J.

Pain. 2017 Dec;158(12):2340-2353. doi: 10.1097/j.pain.0000000000001034. Erratum in: Pain. 2018 Sep;159(9):1904.

9.

Comparison of topical capsaicin and topical turpentine Oil for treatment of painful diabetic neuropathy.

Musharraf MU, Ahmad Z, Yaqub Z.

J Ayub Med Coll Abbottabad. 2017 Jul-Sep;29(3):384-387.

10.

Diabetic Neuropathy Prevalence and Its Associated Risk Factors in Two Representative Groups of Type 1 and Type 2 Diabetes Mellitus Patients from Bihor County.

Andrei Cristian B, Amorin Remus P.

Maedica (Buchar). 2018 Sep;13(3):229-234. doi: 10.26574/maedica.2018.13.3.229.

12.

The contributors of emotional distress in painful diabetic neuropathy.

Selvarajah D, Cash T, Sankar A, Thomas L, Davies J, Cachia E, Gandhi R, Wilkinson ID, Wilkinson N, Emery CJ, Tesfaye S.

Diab Vasc Dis Res. 2014 Jul;11(4):218-225. Epub 2014 May 12.

PMID:
24821753
13.

Painful neuropathy and foot ulceration in diabetic patients.

Veves A, Manes C, Murray HJ, Young MJ, Boulton AJ.

Diabetes Care. 1993 Aug;16(8):1187-9.

PMID:
8375249
14.

Effect of α-lipoic acid on symptoms and quality of life in patients with painful diabetic neuropathy.

Agathos E, Tentolouris A, Eleftheriadou I, Katsaouni P, Nemtzas I, Petrou A, Papanikolaou C, Tentolouris N.

J Int Med Res. 2018 May;46(5):1779-1790. doi: 10.1177/0300060518756540. Epub 2018 Mar 8.

15.

The prevalence of painful diabetic neuropathy in 300 Moroccan diabetics.

Chahbi Z, Lahmar B, Hadri SE, Abainou L, Kaddouri S, Qacif H, Baizri H, Zyani M.

Pan Afr Med J. 2018 Nov 1;31:158. doi: 10.11604/pamj.2018.31.158.14687. eCollection 2018.

16.

Impact of postherpetic neuralgia and painful diabetic peripheral neuropathy on health care costs.

Dworkin RH, Malone DC, Panarites CJ, Armstrong EP, Pham SV.

J Pain. 2010 Apr;11(4):360-8. doi: 10.1016/j.jpain.2009.08.005. Epub 2009 Oct 22.

PMID:
19853529
17.

Chronic pain with neuropathic characteristics in diabetic patients: a French cross-sectional study.

Bouhassira D, Letanoux M, Hartemann A.

PLoS One. 2013 Sep 13;8(9):e74195. doi: 10.1371/journal.pone.0074195. eCollection 2013.

18.

Can metabolic control variables of diabetic patients predict their quality of life?

Dogan H, Harman E, Kocoglu H, Sargin G.

J Am Soc Hypertens. 2016 Jan;10(1):81-8. doi: 10.1016/j.jash.2015.11.014. Epub 2015 Nov 26.

PMID:
26850525
19.

Oxcarbazepine for neuropathic pain.

Zhou M, Chen N, He L, Yang M, Zhu C, Wu F.

Cochrane Database Syst Rev. 2013 Mar 28;(3):CD007963. doi: 10.1002/14651858.CD007963.pub2. Review. Update in: Cochrane Database Syst Rev. 2017 Dec 02;12 :CD007963.

PMID:
23543558
20.

Gabapentin for chronic neuropathic pain and fibromyalgia in adults.

Moore RA, Wiffen PJ, Derry S, Toelle T, Rice AS.

Cochrane Database Syst Rev. 2014 Apr 27;(4):CD007938. doi: 10.1002/14651858.CD007938.pub3. Review. Update in: Cochrane Database Syst Rev. 2017 Jun 09;6:CD007938.

Supplemental Content

Support Center